Literature DB >> 9763339

Meningeal involvement in Behçet's disease: MRI.

A Gumà1, C Aguilera, J Acebes, J Arruga, L Pons.   

Abstract

Behçet's disease is a multisystem disease that involves the central nervous system up to half of cases. Presentation with neurologic symptoms occurs in 5% of cases and cerebral venous thrombosis is one of its major manifestations. A feature not previously reported is progressive meningeal thickening with involvement of both optic nerves. We report a patient with cerebral venous thrombosis, meningeal thickening and contrast enhancement on MRI. This patient had two other unusual features: positive antineutrophil cytoplasmic antibodies and later development of central diabetes insipidus.

Entities:  

Mesh:

Year:  1998        PMID: 9763339     DOI: 10.1007/s002340050635

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  5 in total

1.  Diffusion-weighted MR imaging of neuro-Behçet's disease: a case report.

Authors:  Akio Hiwatashi; Todd Garber; Toshio Moritani; Toshibumi Kinoshita; Per-Lennart Westesson
Journal:  Neuroradiology       Date:  2003-06-18       Impact factor: 2.804

2.  Magnetization transfer ratio in neuro-Behçet disease.

Authors:  Yonca Anik; Zekiye Kural; Ali Demirci; Gür Akansel; Sibel Aksu; Metin Vural
Journal:  Neuroradiology       Date:  2005-01-20       Impact factor: 2.804

3.  Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study.

Authors:  M Rovaris; B Viti; G Ciboddo; S Gerevini; R Capra; G Iannucci; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

Review 4.  Cerebral venous thrombosis in Behçet's disease: a systematic review.

Authors:  D Aguiar de Sousa; T Mestre; J M Ferro
Journal:  J Neurol       Date:  2011-01-06       Impact factor: 4.849

5.  Neuro-Behçet's disease: a report of sixteen patients.

Authors:  Radi Shahien; Abdalla Bowirrat
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.